BeyondSpring Inc. (NASDAQ: BYSI)
$1.6800
+0.0300 ( +0.30% ) 7.2K
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.
Market Data
Open
$1.6800
Previous close
$1.6500
Volume
7.2K
Market cap
$68.90M
Day range
$1.6500 - $1.7200
52 week range
$0.8200 - $4.0000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Form 6-K | 2 | Aug 06, 2024 |
| effect | Other | 1 | Jul 12, 2024 |
| corresp | Comment letters | 1 | Jul 10, 2024 |
| corresp | Comment letters | 2 | Jul 02, 2024 |
| f-3/a | Other | 3 | Jul 02, 2024 |
| upload | Comment letters | 2 | Jun 26, 2024 |
| f-3 | Other | 7 | Jun 12, 2024 |
| 6-k | Form 6-K | 5 | Jun 12, 2024 |
| 424b5 | Other | 1 | Jun 12, 2024 |
| 20-f | Annual reports | 26 | Apr 29, 2024 |